BIVALIRUDIN (BIVALIRUDIN) — FDA Approval ANDA205962 (EUGIA PHARMA)
BIVALIRUDIN (BIVALIRUDIN) — FDA Approval ANDA205962 (EUGIA PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BIVALIRUDIN; Active ingredients: BIVALIRUDIN; Application number: ANDA205962.
| Brand name | BIVALIRUDIN |
|---|---|
| Active ingredients | BIVALIRUDIN |
| Application number | ANDA205962 |
| Sponsor | EUGIA PHARMA |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20180727 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →